The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

15 Nov 2016 16:33

RNS Number : 2602P
Ergomed plc
15 November 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Ergomed Plc

Ord GBP 0.01

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Fullbrook Thorpe Investments LLP

4. Full name of shareholder(s)  (if different from 3.):iv

N/A

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

4th May 2016

6. Date on which issuer notified:

15th November 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

Above 3%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ord GBP 0.01

0

0

1,428,571

1,428,571

3.6%

GB00BN72CY67

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

N/A

N/A

N/A

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

N/A

N/A

N/A

N/A

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

1,428,571

3.6%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

N/A

14. Contact name:

Lucy Thomas

15. Contact telephone number:

01283 753 113

 

Note: Annex should only be submitted to the FCA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

N/A

Contact address

(registered office for legal entities)

 

N/A

Phone number & email

 

N/A

Other useful information

(at least legal representative for legal persons)

 

N/A

B: Identity of the notifier, if applicable

Full name

 

N/A

Contact address

 

N/A

Phone number & email

 

N/A

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

N/A

C: Additional information

For notes on how to complete form TR-1 please see the FCA website.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLAKPDNABDDKDD
Date   Source Headline
2nd Jun 20234:48 pmRNSTR1 Notification
26th May 20238:38 amRNSNotice of AGM and Annual Report
19th Apr 20237:00 amRNSDirector's Dealing
17th Apr 20237:00 amRNSHolding(s) in Company
13th Apr 20233:27 pmRNSHoldings in Company
3rd Apr 20239:51 amRNSHolding(s) in Company
3rd Apr 20237:00 amRNSTotal Voting Rights
30th Mar 20233:37 pmRNSHolding(s) in Company
21st Mar 20237:00 amRNSErgomed Preliminary Results 2022
17th Mar 202311:39 amRNSHoldings in Company
1st Mar 20237:07 amRNSTotal Voting Rights
16th Feb 20231:44 pmRNSHolding(s) in Company
14th Feb 20237:01 amRNSNotice of Preliminary Results
1st Feb 20237:00 amRNSTotal Voting Rights
25th Jan 20237:00 amRNSJonathan Curtain appointed CFO
25th Jan 20237:00 amRNSErgomed 2022 Trading Update
20th Jan 20235:23 pmRNSHolding(s) in Company
20th Jan 20239:38 amRNSHolding(s) in Company
3rd Jan 20237:00 amRNSTotal Voting Rights and Block Listing Return
5th Dec 20227:00 amRNSDirector Dealings
2nd Dec 20227:00 amRNSJohn Dawson appointed Senior Independent Director
1st Dec 20227:00 amRNSTotal Voting Rights
22nd Nov 20227:00 amRNSExercise of Share Options and Total Voting Rights
21st Nov 202210:46 amEQSErgomed (ERGO): Two key management changes
17th Nov 20227:00 amRNSErgomed Strengthens Executive Management Team
16th Nov 20227:00 amRNSExercise of Share Options and Total Voting Rights
1st Nov 20224:16 pmRNSExercise of Share Options and Total Voting Rights
1st Nov 20227:00 amRNSTotal Voting Rights
20th Oct 20222:09 pmRNSHolding(s) in Company
14th Oct 20224:09 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSHolding(s) in Company
4th Oct 202212:52 pmEQSErgomed (ERGO): Poised for a strong FY22
3rd Oct 20227:00 amRNSTotal Voting Rights
27th Sep 20227:00 amRNSErgomed Interim results 2022
2nd Sep 20227:00 amRNSHolding(s) in Company
1st Sep 20227:00 amRNSTotal Voting Rights
25th Aug 20227:00 amRNSErgomed Notice of Results
19th Aug 20222:49 pmRNSHolding(s) in Company
1st Aug 20228:10 amEQSErgomed (ERGO): Sustained growth momentum in H122
1st Aug 20227:00 amRNSDirector Dealing
1st Aug 20227:00 amRNSTotal Voting Rights
26th Jul 20227:00 amRNSErgomed H1 2022 Trading Update
1st Jul 20227:00 amRNSTotal Voting Rights and Block Listing Return
10th Jun 202211:21 amRNSResults of 2022 Annual General Meeting
10th Jun 20227:00 amRNSErgomed Annual General Meeting Statement
10th Jun 20227:00 amRNSAnne Whitaker appointed to the Board as NED
1st Jun 20227:00 amRNSErgomed plc Total Voting Rights
13th May 20227:00 amRNSErgomed Notice of AGM and Annual Report
3rd May 20228:49 amRNSErgomed plc Total Voting Rights
28th Apr 20227:01 amEQSErgomed (ERGO): Healthy fundamentals for 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.